Bing Yuan

Chief Executive Officer at OnCusp Therapeutics6

Commercial Services

Profile

Bing Yuan is the founder of OnCusp Therapeutics, Inc. He is currently working as the Executive Director at Shanghai OnCusp Pharmaceutical Co. Ltd.

Bing Yuan active positions

Companies	Position	Start
OnCusp Therapeutics6 OnCusp Therapeutics6 Miscellaneous Commercial ServicesCommercial Services OnCusp Therapeutics is a biotechnology company based in New York, NY and has subsidiaries in China. OnCusp Therapeutics specializes in developing preclinical assets to clinical proof of concept and then partnering out for commercialization in the field of oncology therapeutics. The company is committed to accelerating the advancement of oncology assets by leveraging its deep translational and clinical development expertise. OnCusp Therapeutics is backed by prominent investors including Sequoia Capital, Biotrack Capital, Oriza Seed Capital, and AIHC Capital. The company was founded in 2021 by Andy Fu, Bing Yuan, and Eric Slosberg, with Bing Yuan serving as the CEO since then.	Chief Executive Officer	-
Shanghai OnCusp Pharmaceutical Co. Ltd.	Director/Board Member	-

All active positions of Bing Yuan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bing Yuan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
OnCusp Therapeutics6 OnCusp Therapeutics6 Miscellaneous Commercial ServicesCommercial Services OnCusp Therapeutics is a biotechnology company based in New York, NY and has subsidiaries in China. OnCusp Therapeutics specializes in developing preclinical assets to clinical proof of concept and then partnering out for commercialization in the field of oncology therapeutics. The company is committed to accelerating the advancement of oncology assets by leveraging its deep translational and clinical development expertise. OnCusp Therapeutics is backed by prominent investors including Sequoia Capital, Biotrack Capital, Oriza Seed Capital, and AIHC Capital. The company was founded in 2021 by Andy Fu, Bing Yuan, and Eric Slosberg, with Bing Yuan serving as the CEO since then.	Commercial Services
Shanghai OnCusp Pharmaceutical Co. Ltd.